Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Recruiting
Observational Study
Behcet Disease
Antineutrophil Cytoplasmic Antibody (ANCA) Positive Vasculitis
Takayasu Arteritis
Giant Cell Arteritis
Sjogren's Syndrome
Rheumatoid Arthritis
Hereditary and Acquired Angioedema
Primary Antiphospholipid Syndrome
Celiac Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 800 (estimated)
- Sponsor
- Santé Arménie French-Armenian Research Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases:
Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ank…
Contacts